Disney rejects Trian's board seats request: Insider trades & hedge funds weekly
Investing.com — Here is your Pro Recap of the biggest insider trades and institutional investor headlines you may have missed this week: Walt Disney turns down Trian request for Board representation, Elliott takes $1 billion stake in Phillips 66 and seeks board seats, and top brass buys at Arbor Realty Trust , Agilon Health, and 3D Systems.
Unlock the potential of InvestingPro for up to 60% off this Cyber Monday Extended and never miss out on a market winner again.
Trian Fund Management, led by activist investor Nelson Peltz, announced that their request for board representation at Walt Disney (NYSE:DIS) was rejected. Holding about $3 billion in Disney shares, Trian disclosed that despite discussions with Disney's CEO and an invitation to meet with the board, their proposal for board seats, including one for Peltz, was declined.
This comes after reports stated that Peltz might nominate at least three directors for Disney's board.
«Since we gave Disney the opportunity to prove it could 'right the ship' last February, up to our re-engagement weeks ago, shareholders lost ~$70 billion of value,» said Trian in its statement, noting low investor confidence and looming key strategic questions.
Trian's latest statement follows the appointment of James P. Gorman, Morgan Stanley's chairman and CEO, and veteran media executive Jeremy Darroch as new Disney directors. While acknowledging these appointments as positive, Trian believes they are insufficient to regain investor trust or address the fundamental problems under the current board's oversight. Trian plans to take the case for change directly to shareholders.
Elliott Investment Management has taken a position worth $1B in Phillips 66 (NYSE:PSX) and is pushing to appoint two
Read more on investing.com
